Impact of prenatal and postnatal exposure to bisphenol A on female rats in a two generational study: Genotoxic and immunohistochemical implications  by Moustafa, Gihan G. & Ahmed, Amal A.M.
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Environmental  xenoestrogen  contaminant  bisphenol  A (BPA),  widely  used  as  a monomer  in the  man-
ufacture  of epoxy,  polycarbonate  plastics  and  polystyrene  resins.  However,  exposure  to BPA  has  raised
concerns,  and  the  negative  impacts  of  its  exposure  on reproduction  have  been  controversial.  The  purpose
of this  work  was  directed  to  assess  the  potential  adverse  effects  of BPA  on  dam  rats  and  their  ﬁrst  genera-
tion  females  in  a comparative  toxicological  study.  Fifteen  pregnant  female  rats  were  classiﬁed  into  three
equal groups;  ﬁrst group  was  orally  administered  corn  oil and served  as  control  (group1),  second  and
third  groups  were  orally  administered  BPA  at dose  levels  of  50 and  200  mg/kg  b.wt  respectively  (groups  2
& 3).  The  administration  was  carried  out  daily from  zero  day  through  the gestation  period  (21  days)  until
the  last day  of  the  lactation  period  (21days)  and  was  extended  after  weaning  for  three  months,  in  which
female  off springs  of  ﬁrst  generation  (F1)  of  the three  groups  of dams  were  classiﬁed  into;  F1control
group  (group  4),  F1  group  treated  with  low  dose  of  BPA  (group  5) and  F1 group  treated  with  high  dose
of  BPA  (group  6)  which  continued  in  daily  oral  administration  of BPA  at  the  same  previously  mentioned
doses  for  three  months.  The  results  elucidated  a clear  marked  DNA  fragmentation  in  the  ovary  of  both
dam and  F1  female  groups  especially  at  higher  examined  concentration.  Also,  the  data  demonstrated
a  signiﬁcant  increase  in  the  serum  levels  of  GGT,  ALP,  glucose,  total cholesterol,  triglycerides,  LDH  and
also  in the  serum  level  of  estrogen  hormone.  Meanwhile,  our  study  recorded  a signiﬁcant  decrease  in
total protein,  catalase,  GST,  HDL  and  FSH  hormone  in  both  treated  dam  and  F1  female  groups  which  was
more signiﬁcantly  decreased  in  F1  female  rats.  Moreover,  our experiment  illustrated  up-regulation  in the
immunoexpression  of  ER in  ovary,  uterus  and  liver  of dam  and  F1  female  groups.  The  histopathologi-
cal investigation  showed  degeneration  in  the  epithelial  lining  of  ovarian  follicles,  submucosal  leukocytic
inﬁltration  and  increase  in  vaculation  of hepatic  cells with  proliferation  of  kupffer  cells.  The  lesions  were
more sever  in  groups  3 &  6 of  both  dam  and  their  F1  females.  Our  data  speculated  that  long-  term  exposure
to  BPA  at 50  and  200  mg/kg.b.wt.  depicted  total genomic  damage,  signiﬁcant  alterations  in liver  enzymes,
lipid  proﬁle,  antioxidant  enzymes  and reproductive  hormones  with  up-regulation  in  the  expression  of
ER which  were  more  signiﬁcantly  perturbed  in  group  3 and  group  6  of both  dam  and  F1 female  rats.
© 2016  Published  by Elsevier  Ireland  Ltd.  This  is an  open  access  article  under  the  CC  BY-NC-ND. IntroductionMany environmental chemicals recently, are considered as
enoestrogens and endocrine disruptors [31,7]. Nowadays, there is
rowing concern regarding the impact of environmental chemicals
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on animal and human reproduction [19]. Such endocrine disruptors
may  represent a major toxicological and public health issue [35].
The xenoestrogen bisphenol A (BPA) has received much attention
due to its high production volume and wide spread exposure [24].
Bisphenol A {BPA; 2,2-bis-(4-hydroxyphenyl) propane} is a
plasticizer that is widely used to produce polycarbonate plastic,
epoxy resin and unsaturated polystyrene. BPA can leach from lin-
ings of food cans, polycarbonate baby bottles and other beverage
containers, dental sealants and composites, polyvinyl chloride plas-
tics and recycled thermal paper [60]. This compound released to
the environment both accidentally and through permitted dis-
the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).
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harges [53] and its wide spread distribution has been a major
ause of concern to regulatory agencies and others [45]. Its lifetime
n the environment is sufﬁcient for it to be virtually permanently
etectable and it has been described as ubiquitous in surface waters
29].
Christiansen et al. [11] examined the inﬂuence of BPA (5 and
0 mg/kg b.wt.) on early sexual development in male and female
ats, they recorded signiﬁcant decrease in anogenital distance of
oth sexes besides; the incidence of nipple retention in male
ppeared to increase.
Studies on BPA genotoxicity have conﬂicting results; both geno-
oxic [37] and non- genotoxic [21] effects of BPA have been
eported. Where, studies of BPA genotoxicity have yielded con-
icting results; BPA is considered non-genotoxic because it was
egative to a set of basic genotoxicity tests [49], did not induce gene
utations [57] or chromosomal aberrations [23]. In contrast, BPA
nduced numerical chromosomal aberrations and morphological
hanges in cultured Syrian Hamster Embryo cells [57]. In addition,
PA metabolites were shown to bind to DNA in a cellular system
13].
It was reported that BPA induce oxidative stress [28], in which
eactive oxygen species (ROS) are cytotoxic agents that lead to
igniﬁcant oxidative damage by attacking biomolecules such as
embrane lipids and DNA in cells [27].
A few studies have focused on whether BPA exerts its action
hrough nuclear receptors such as estrogen [50], androgen [56]
nd thyroid [44] receptors. Further, Peretz et al. [40] have shown
hat BPA does not exert its toxic effects via the genomic estrogenic
athway in mouse ovarian follicles.
Meanwhile, in vitro studies demonstrated that BPA binds to the
strogen receptors induces estrogen − dependant gene expression
esponses [30] and Caserta et al. [9] mentioned that BPA has estro-
enic activity and binds to  and to a lesser extent to -estrogen
eceptors. Further BPA can acts as antiestrogen, blocking these
strogen response by competing with endogenous estrogen [42].
In this spirit and because there is paucity of information con-
erning studying the comparative toxic impacts from long-term
xposure to BPA on dam rats and their female generations. We
how in this study for the ﬁrst time the effects of BPA in a com-
arative manner on dam rats and their ﬁrst generation females
oncerning DNA damage, expression of estrogen receptor , with
ome biochemical parameters and histopathological examination
f liver and reproductive organs.
. Materials and methods
.1. Chemical compound
Bisphenol A (purity 97% of CAS number 80-50-7) was  obtained
rom sigma- Aldrich Company and dissolved in corn oil [32].
.2. Animals and dosing
Eighty mature albino rats (sixty of females weighing
50–200 gm b.wt. and twenty of males weighing 220–260 gm
.wt., used for mating) were obtained from experimental Animal
nit of Faculty of Veterinary Medicine, Zagazig University, Egypt.
nimals were kept in metal cages under hygienic conditions,
ed on well balanced ration and provided with water ad-libitum
hroughout the experiment.Experiments were conducted in accordance with the guidelines
et by Animals Health Research Ethics Training Initiative, Egypt, and
xperimental protocols were approved by the institutional animal
thics committee.logy Reports 3 (2016) 685–695
Female dam rats were daily examined to ensure estrous phase
using vaginal smear technique, females in estrous were paired with
mature males, the presence of sperms in vaginal smear indicating
zero day of gestation [4]. Fifteen pregnant female rats were classi-
ﬁed into three equal groups; ﬁrst dam group orally administered
corn oil and served as control (group1), second dam group orally
administered BPA at dose level of 50 mg/kg b.wt. [61] (group2) and
third dam group orally administered BPA at dose level of 200 mg/kg
b.wt. [48] (group3). The administration was  carried out daily from
zero day throughout the gestation period (21days) until the last day
of lactation period (21days) and extended after weaning for three
months.
After weaning, female off springs of ﬁrst generation (F1) of the
three groups of dams; each group contain seven females of F1 were
classiﬁed into; F1control group (group 4), F1 group treated with
low dose of BPA (group 5) and F1 group treated with high dose of
BPA (group 6) which continued in oral daily administration of BPA
at the same previously mentioned doses for three months.
At the end of the experiment, blood samples were collected
from the retro-orbital sinus without anticoagulant in sterile test
tubes for separation of serum which kept at −20 ◦C till biochem-
ical analysis and then dam rats of the three groups and their F1
females that examined for pro-estrus phase were anesthetized
and euthanized by decapitation. Tissue samples from ovaries of
all groups were taken and kept at −20 ◦C for applying DNA frag-
mentation assay. For immunohistochemical and histopathological
studies, specimens from ovary, uterus and liver were collected and
ﬁxed in 10% buffered neutral formalin solution.
2.3. DNA fragmentation assay
DNA damage determined by DNA fragmentation assay accord-
ing to Bortner et al. [8] that could be summarized as following:
Small pieces of ovarian tissues were put in 1.5 ml  microfuge
tube. Extraction buffer was added to 0.3 ml  mark. Tissues were
crushed and then extraction buffer was added till 0.5 ml mark.
50.0 l of proteinase-K solution (10.0 mg/ml) was added then the
tubes were closed and inverted to mix. Tubes were incubated at
50 ◦C for 12 h: 3 days with occasional vigorous mixing. DNA was
extracted with a mixture of phenol, chloroform and isoamyl alco-
hol (25: 24: 1) and vortex samples 5.0 s. Samples were centrifuged
at 12000 rpm for 5.0 min. Then 500 l of aqueous layer for each
sample was removed carefully into a new tube and 50.0 l of 3.0 M
sodium acetate (pH = 5.3) was added to each tube. Pure ethanol
(100%) was  added till mark 1.5 ml.  The tubes were inverted for mix-
ing and DNA precipitation then let to be set at −20 ◦C overnight and
centrifuged at 12000 rpm for 20 min. The supernatant was removed
and 50.0 l of Tris EDTA buffer was  added overnight till complete
dissolving. Samples were run on electrophoresis using 1.2% agarose
gel at 50.0 voltages, gel was stained using ethidium bromide. Sam-
ples were analyzed using image analyses software.
2.4. Immunohistochemical examination for determination of
estrogen receptor–  ˇ (ERˇ)
The parafﬁn embedded ovaries, uteri and livers were ﬁxed in
10% formalin, sectioned into 5 m sections, and mounted on pos-
itively charged slides for immunostaining of ER.  Sections were
deparafﬁnised, rehydrated and autoclaved at 120 ◦C for 10 min  in 10
Mm citrate buffer (pH 6) for ER.  After washing with PBS endoge-
nous peroxidase was blocked using 0.3% hydrogen peroxide in
methanol (15 min). Thereafter, slides were washed in PBS again
and blocking was performed by adding blocking buffer and incu-
bated for 30 min  at room temperature. Primary antibody for ER
(Cat. No. RB- 10658-R7, Thermo Scientiﬁc Co., UK). It was diluted
by PBS (1:100) then added to the slides and incubated for 30 min.
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Fig. 1. Effect of BPA administration at dose levels of (50 & 200 mg/kg b.wt) on ovarian
DNA fragmentation of dam rats and their F1 females. Lane 1: no DNA fragmentation
of  control group of dam (group 1). Lane 2: mild DNA fragmentation of dam treated
with low dose of BPA (group 2). Lane 3: strong DNA fragmentation of dam treated
with high dose of BPA (group 3). Lane 4: no DNA fragmentation of control group ofG.G. Moustafa, A.A.M. Ahmed / T
he slides subjected to washing with PBS three times for 3 min
ach. Biotinylated polyvalent secondary antibody (Cat. No. 32230,
hermo Scientiﬁc Co., UK) was applied to tissue sections and incu-
ated for 30 min. The slides were washed three times for 3 min  each
ith wash buffer and then incubated with avidin-biotincomplex
ABC peroxidase kit, Santa Cruz, USA). Slides were incubated for ten
inutes with DAB peroxidase enzyme substrate. They were washed
ith buffer two times for 3 min  each. Sections were counterstained
ith hematoxylin stain then slides were dehydrated, cleared and
ounted [3]. For negative controls, sections were treated with
imilar steps with the exception of the primary antibodies. Posi-
ive immunoreactivity was recognized as brown staining. Images
ere captured from ovaries, uteri and livers using a Canon power
hot digital camera (Canon, Inc., Tokyo, Japan) for light microscopic
xamination.
.5. Serum biochemical analysis
The sera were analyzed for estimation of gamma  glutamyl
ransferase (GGT), alkaline phosphatase (ALP) and total protein
sing commercially available kits (Biosystem S.A., Costa Brava., 30,
arcelona, Spain) according to instructions of manufacture. Glucose
as calculated according to Glick et al. [17], catalase activity (CAT)
ccording to the method described by Sinha [52], glutathione S
ransferase activity (GST) according to Habig et al. [20], total choles-
erol according to Allain et al. [1], triglycerides according to Fossatic
nd Prenicined [14], high density lipoprotein C (HDL-c) according
o Lopes- Vurella et al. [33], low density lipoprotein −c (LDL-c) was
alculated according to Friedwald et al. [15], follicular stimulating
ormone (FSH) was estimated using the assay described by Beastall
t al. [5] and estrogen hormone was measured using commercial
mmunoassay kit (vat estradiol ELISA kit, cubio, USA).
.6. Histopathological examination
Ovary, uterus and liver specimens were routinely processed by
ehydration in gradual ethanol (70–100%), cleared in xylene and
he parafﬁn embedded tissues were cut 5 m thick and then rou-
inely stained with haematoxylin and eosin (H&E) dyes according
o Bancroft and Gamble [2].
.7. Statistical analysis
Data are expressed as mean values ± SE. Statistical analysis was
erformed using one way analysis of variance (ANOVA) using SPSS
tatistical version 21 software package (SPSS, Inc, USA). Duncan’s
est was used for making a multiple comparisons among the groups
or testing the inter-grouping homogeneity. The signiﬁcance was
eclared at (P < 0.05).
. Results
.1. Effect of BPA on ovarian total genomic damage of DNA
Fig. 1 showed electrophoretic pattern of ovarian total genomic
NA fragmentation of control and treated groups with BPA at both
oncentrations (50 mg  & 200 mg/kg B.wt.) of dam and F1 female
ats. Bisphenol A revealed strong DNA damage at the examined
oses which was more obvious at higher concentration comparing
ith the low toxic dose in both dam and F1 female treated groups
groups 3&6). DNA damage represented by fragments migrated
rom the wells. On the contrary, control groups of dam and F1
emale did not revealed fragmentation of DNA.F1  female (group 4). Lane 5: moderate DNA fragmentation of F1 female treated with
low  dose of BPA (group 5). Lane 6: strong DNA fragmentation of F1 female treated
with high dose of BPA (group 6).
3.2. Effect of BPA on serum biochemical parameters of dam rats
and their F1 females
Table 1 indicated that dam rats and their F1 females orally
administered BPA at dose levels of (50 & 200 mg/kg b.wt.) showed
signiﬁcant increase (P < 0.05) in serum levels of GGT, ALP and glu-
cose comparing with their corresponding control ones and when
comparing between the treated groups meanwhile, glucose level
was not signiﬁcantly increased when comparing group 3 of dam
with group 5 of F1 female. The levels of GGT, ALP and glucose were
more signiﬁcantly increased in F1 female groups when comparing
with their corresponding dam groups.
On the contrary, Table 1 illustrated signiﬁcant decrease (P < 0.05)
in the serum levels of total protein, catalase and GST in all treated
groups comparing with the control rats of both dam and F1 female
groups but the levels of total protein and GST were not signiﬁ-
cantly decreased when comparing group 3 of dam with group 5
of F1 female and also, when comparing both group 5 and group 6
of F1 females concerning the level of total protein.
Regarding the picture of lipid proﬁle, Table 2 recorded sig-
niﬁcant increase (P < 0.05) in the levels of total cholesterol,
triglycerides and HDL and signiﬁcant decrease (P < 0.05) in the level
of LDL in the treated groups of both dam rats and their F1 female
groups comparing with control and when comparing with each
other, otherwise the level of HDL was not signiﬁcantly increased
when comparing group 3 of dam with group 5 of F1 females and
when comparing both treated groups of F1 females with each other.
Also, our data depicted in Table 2 showed signiﬁcant decrease
(P < 0.05) in the serum level of FSH and signiﬁcant increase in the
estrogen level in the treated rats of both dam and F1 female groups
comparing with the control rats. Meanwhile, the level of FSH was
not signiﬁcantly decreased when comparing group 2 of dam with
the corresponding control one and also, FSH level was not signiﬁ-
cantly decreased when comparing both group 2 and group 5 of dam
rats and their F1 females. Besides, the level of estrogen was signif-
icantly increased when comparing group 3 of dam with group 5 of
F1 females. Also, the level of estrogen in group 6 was signiﬁcantly
higher than that of group 5.
3.3. Immunhistochemical detection of estrogen receptor–  ˇ (ERˇ)Our study showed faint immunoreactions of ER expression in
ovary, uterus and liver of control groups (groups 1 & 4) of dam
and F1 female (Fig. 2A, B & Fig. 3A, B & Fig. 4A, B). The ovary of
dam treated with BPA (50 mg/kg b.wt) (group2) revealed moder-
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Fig. 2. Immunolocalization of estrogen receptor- in proestrus phase in ovary of: control group of dam (group1) (A) and F1 female (group 4) (B) showing faint immunoreac-
tivity  in the cellular component of corpus luteum (*), the ovarian follicles were devoid of staining afﬁnity (arrow). Group 2 of dam (C) showed moderate immunoreactivity
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garrow) and F1 female (group 5) (D) showing strong immunoreactivity in the corpu
oderate reaction in the stromal cells (*), ovarian follicles (arrowhead) and corpus
tromal  cells (*) and moderate in the ovarian follicles (arrow) (immunostaining sca
te reaction (Fig. 2C) and of F1 female (group 5) showed intense
mmunoreaction (Fig. 2D). Groups treated with BPA (200 mg/kg
.wt) of dam and F1 female (groups 3 & 6) showed moderate and
trong reaction respectively (Fig. 2E, F).
The uterus of group 2 of dam revealed moderate immunore-
ction (Fig. 3C) and of F1 female (group 5) showed more intense
eaction (Fig. 3D). In addition, group 3 of dam indicated mild to
oderate reaction (Fig. 3E) and of F1 female (group 6) revealed
ost intense immunoreaction (Fig. 3F).
The liver showed mild to moderate reaction of group 2 of dam
Fig. 4C) and revealed moderate to strong reaction of F1 female
roup (group 5) (Fig. 4D). Group 3 and group 6 of dam and F1 female
howed moderate and strong immunoreaction respectively (Fig. 4E,
)..4. Histopathological ﬁndings
The ovary showed normal histological architecture of control
roups of dam and their F1 females (Fig. 5A, B). Groups treated withm (*), ovarian follicles and stromal cells (arrowhead). Group 3 of dam (E) showing
m (arrow), and F1 female (group 6) (F) showing an intense staining afﬁnity of the
 100 m and inset scale bar 20 m).
BPA (50 mg/kg b.wt.) of dam (group 2) showed degeneration in the
epithelial lining of ovarian follicles (arrow) and leukocytic inﬁltra-
tion in interstitial tissue (arrowhead) (Fig. 5C) and of F1 females
(group 5) showed secondary follicle and mild congested blood ves-
sel (arrow) (Fig. 5D). Groups treated with BPA (200 mg/kg b.wt.)
of dam (group 3) showed congestion (arrow), hemorrhage (arrow-
head) and degenerated ovum (*) (Fig. 5E) and of F1 females (group
6) showed degenerated ovum (arrow) and interstitial leukocytic
inﬁltration (arrowhead) (Fig. 5F).
The uterus of control groups (groups 1 & 4) of dam and F1
females showed normal histological structures of epithelial lin-
ing (*), and glandular units (arrow) and stromal tissue (arrowhead)
(Fig. 6A,B). Group 2 of dam revealed cystic dilatation of endometrial
gland (arrow), submucosal leukocytic inﬁltration and hyperpla-
sia of endometrial epithelium (arrowhead) (Fig. 6C) and of F1
females (group 5) showed endometrial hyperplasia with invagina-
tions (arrow) (Fig. 6D). Group 3 of dam showing diffuse leukocytic
inﬁltration (arrow) with vacuolar degeneration in endometrial
epithelium (arrowhead) and glandular epithelium (*) (Fig. 6E) and
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Fig. 3. Immunolocalization of estrogen receptor- in proestrus phase in uterus of: control group of dam(group 1) (A) showing faint immunoreactivity throughout the stromal
cells,  the lining epithelium of the endometrium and uterine gland were devoid of immunoreactivity (*) and F1 female (group 4) (B) showing faint reaction in the deep stromal
cells  (*), the lining epithelium of the endometrium was  more intense than that of uterine gland. Group 2 of dam (C) showing moderate reaction in the stromal cells and
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andometrial epithelium and F1 female (group 5) (D) showing more intense reaction
he  epithelium of endometrium and uterine glands and showing mild to moderate r
mmunoreactivity in the stromal cells (arrow) (immunostaining scale bar 50 m an
f F1 female (group 6) showing multiple cyst formation in endome-
rial glands (arrow) with diffuse interstitial leukocytic inﬁltration
Fig. 6F).
The liver revealed normal histological structure of control
roups (groups 1 & 4) (Fig. 7A, B). Group 2 of dam showed hydropic
egeneration and pyknosis of the nuclei (arrow) (Fig. 7C) and
evealed sever hydropic degeneration and coagulative necrosis
arrow) in F1 female group (group 5) (Fig. 7D). In addition group
 of dam showing increase in vacoulation of hepatic cells (arrows)
Fig. 7E) and revealed sever hydropic degeneration (arrows), coag-
lative necrosis, sinusoidal dilatation, pyknosis and proliferation of
upffer cells (arrowheads) in F1 female group (group 6) (Fig. 7F).
. DiscussionThe current study is considered the ﬁrst work for evaluating in
 comparative manner the toxic impacts of BPA exposed dam rats
nd their F1 females concerning ovarian genotoxicity, effect on the superﬁcial stromal cells (arrow). Group 3 of dam (E) showing moderate reaction in
n in the stromal cells (arrow) and F1 female (group 6) (F) showing the most intense
t scale bar 20 m).
expression of ER accompanying with biochemical and histopatho-
logical investigations.
Using the genotoxicity tests in vivo models plays a crucial role
in the risk assessment process [58]. Few short − term studies have
been carried out on the genotoxic potential of BPA using in vivo test
models [26], In addition few papers have described the effects of
BPA on somatic cells, and most of those are studies in males [16].
The present study indicated that BPA at both examined concen-
trations revealed marked DNA damage using DNA fragmentation
assay in the ovary of all treated rats of dam and their F1 female
groups in which the fragmentation was more clear in groups 3 &
6 comparing with groups 2 & 5 (Fig. 1). In this manner Tayama
et al. [55] detected an increase in DNA migration after treatment
of CHO −K1 cells with PBA. On the other hand De  ﬂora et al. [12]
recorded that there was  no increase of single strand DNA breaks in
cells of BPA − treated rats, including peripheral blood lymphocytes
and bone marrow erythrocytes. In which Ulutas et al. [58] reported
that the genotoxic effects of BPA is controversial.
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Fig. 4. Immunolocalization of estrogen receptor- in proestrus phase in liver of control group of: dam (group 1) (A) and F1 female (group 4) (B) sowing faint immunoractivity.
Group  2 of dam (C) sowing mild to moderate reaction and F1 female (group 5) (D) showing moderate to strong reaction. Group 3 of dam (E) showing moderate reaction and
F1  female (group 6) (F) showing strong reaction (immunostaining scale bar 50 m and inset scale bar 20 m).
Table 1
Effects of PBA orally administered at dose levels of (50 mg  & 200 mg/kg.b.wt.) to dam rats and their ﬁrst generation females on serum liver enzymes, total protein, glucose,
catalase and glutathione S − transeferase. (Mean ± SE) (n = 5).
Groups Parameters
GGT
(u/L)
ALP
(IU/L)
Total protein
(gm/dl)
Glucose
(mg/dl)
Catalase
(u mol H2O2
Decomposed/ml)
GST
(U/L)
Group1 (Control dam) 24.99 ± 0.14e 69.14 ± 0.3e 8.1 8 ± 0.30a 84.08 ± 0.73d 41.10 ± 0.28a 13.32 ± 0.15a
Group 2 (Dam treated with Low dose of BPA) 32.66 ± 0.16d 78.83 ± 0.24d 8.01 ± 0.06b 96.34 ± 0.22c 39.86 ± 0.19b 11.43 ± 0.41b
Group 3 (Dam treated with High dose of BPA) 38.64 ± 0.32b 86.84 ± 0.21c 7.14 ± 0.20cd 104.61 ± 0.32b 35.59 ± 0.16c 9.59 ± 0.21c
Group 4 (Control F1 female) 24.51 ± 0.13e 68.49 ± 0.24e 8.30 ± 0.41a 85.23 ± 0.36d 40.61 ± 0.83a 13.61 ± 0.18a
Group 5 (F1 female treated with Low dose of BPA) 36.90 ± 0.23c 91.90 ± 0.64b 7.12 ± 0.52de 102.41 ± 0.67b 34.03 ± 0.17d 9.75 ± 0.21c
 0.80a
M ifferen
i
cGroup 6 (F1 female treated with High dose of BPA 41.92 ± 0.19a 112.70 ±
eans within the same column having the different superscripts are signiﬁcantly d
One pathway of BPA metabolism is the hydroxylation of one of
ts symmetric phenyl rings to form its catechole, O-OH BPA, which
an oxidize to O-quinone BPA [47] which in turn, react with DNA.6.96 ± 0.81e 127.52 ± 0.58a 30.43 ± 0.26e 7.52 ± 0.91d
t at (P < 0.05).
O-Quinone BPA forms predominantly depurinating adducts O-
OH-BPA −6-N3 Ade and O-OH-BPA −6-N7Gua [28]. Moreover,
Sakuma et al. [46] detected that O-quinone BPA could increase ROS
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Fig. 5. Ovarian sections of control group of dam (group 1) (A) and F1 female (group 4) (B) showing normal histological structure of ovarian follicles (*). Group 2 of dam
treated with low dose of BPA (C) showing degeneration in the epithelial lining of ovarian follicles (arrow) and leukocytic inﬁltration in the interstitial tissue (arrowhead) and
F1  female (group 5) (D) showing secondary follicle and mild congested blood vessel (arrow). Group 3 of dam treated with high dose of BPA (E) showing congestion (arrow),
haemorrhage (arrowhead) and degenerated ovum (*) and of F1 female (group 6) (F) showing degenerated ovum (arrow) and interstitial leukocytic inﬁltration (arrowhead)
HE  x 400.
Table 2
Effects of PBA orally administered at dose levels of (50 mg  & 200 mg/kg.b.wt.) to dam rats and their ﬁrst generation females on serum levels of lipid proﬁle, FSH and estrogen
hormones. (Mean ± SE) (n = 5).
Groups Parameters
Total cholesterol
(mg/dl)
Triglycerides
(mg/dl)
HDL
(mg/dl)
LDL
(mg/dl)
FSH
(IU/L)
Estrogen
(pg/ml)
Group1 (Control dam) 90.81 ± 0.58e 80.57 ± 0.41e 50.20 ± 0.59a 30.48 ± 1.02e 3.71 ± 0.80ab 26.71 ± 0.25d
Group 2 (Dam treated with Low dose of BPA) 98.21 ± 0.84d 85.59 ± 0.27d 46.61±0.41 34.41 ± 0.51d 3.43 ± 0.32bc 29.46 ± 0.31c
Group 3 (Dam treated with High dose of BPA) 105.20 ± 0.37c 88.58 ± 0.23c 42.46 ± 0.29cd 45.32 ± 0.92b 2.95 ± 0.30d 31.49 ± 0.55b
Group 4 (Control F1 female) 92.40 ± 0.42e 82.30 ± 0.58e 49.35 ± 0.31a 31.47 ± 0.36e 3.87 ± 0.61a 25.93 ± 0.43d
Group 5 (F1 female treated with Low dose of BPA) 107.80 ± 0.34b 106.41 ± 0.28b 43.41 ± 052c 41.34 ± 0.62c 3.29 ± 0.45c 30.75 ± 0.53bc
08.18
M ifferen
f
t
nGroup 6 (F1 female treated with High dose of BPA) 112.10 ± 0.53a 1
eans within the same column having the different superscripts are signiﬁcantly dormation and oxidize the guanine moiety of deoxyguanosine in
he DNA of primary rat hepatocyte culture.
In the same context our data of the present study recorded sig-
iﬁcant decrease in serum levels of antioxidant enzymes; catalase ± 0.72a 41.23 ± 0.65d 49.16 ± 0.93a 2.57 ± 0.41e 36.66 ± 0.75a
t at (P < 0.05).and GST in groups 2 & 3 of dam, which were more signiﬁcantly
decreased in groups 5& 6 of F1 females (Table 1).
Our results came in harmony with those reported by Kab-
uto et al. [27] who  found that intraperitoneal administration of
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Fig. 6. Uterine sections of control groups of dam (group 1) (A) & F1 female (group 4) (B) showing normal histological structure of epithelial lining (*), and glandular units
(arrow) and stromal tissue (arrowhead). Group 2 of dam treated with low dose of BPA (C) showing cystic dilatation of endometrial gland (arrow), submucosal leukocytic
i ale (gr
o row) 
e dome
5
i
l
p
s
g
c
t
a
a
onﬁltration and hyperplasia of endometrial epithelium (arrowhead) and of F1 fem
f  dam treated with high dose of BPA (E) showing diffuse leukocytic inﬁltration (ar
pithelium (*) and of F1 female (group 6) (F) showing multiple cyst formation in en
0 mg/kg b.wt. of BPA reduced the activity of detoxifying enzymes,
ncluding superoxide dismutase, glutathione peroxidase and cata-
ase in mouse tissue. Also, Popa et al. [41] recorded increased lipid
eroxidation and decreased activity of some antioxidant enzymes
uch as catalase, glutathione peroxidase, glutathione reductase and
lutathione S-transferase in female rats treated with BPA. In which,
atalase may  reﬂect inability of liver mitochondria and microsomes
o eliminate hydrogen peroxide produced after exposure to BPA [6]
nd GST protects cells or tissue against oxidative stress and dam-
ge by detoxifying various toxic substrates derived from cellular
xidative processes [51].oup 5) (D) showing endometrial hyperplasia with invaginations (arrow). Group 3
with vacuolar degeneration in endometrial epithelium (arrowhead) and glandular
trial glands (arrow) with diffuse interstitial leukocytic inﬁltration. HE x 400.
Previous study strongly suggested that DNA damage induced by
estrogen is dependent on estrogen receptors (ER) [22].
Regarding to the effect of both examined doses of BPA on the
expression of estrogen receptor (ER), our study revealed that there
were mild to strong immunoreactions of ER in ovary, uterus and
liver of both dam (groups 2 & 3) and F1 female groups (groups 5 &
6) in which the expression was more clear in F1 groups comparing
with dam rats (Figs. 2–4). Similarly, Rodiguez et al. [43] found that
PBA caused an increase in the expression of ER in rat’s ovary. Con-
versely, Vandenberg et al. [59] reported that BPA is a weak estrogen
agonist and so its effects observed in animal studies are difﬁcult
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Fig. 7. Sections of liver of control group (group 1) (A) and F1 female (group 4) (B) showing normal histological structure. Group 2 of dam treated with low dose of BPA (C)
s le (gro
G hepat
( upffer
t
s
s
p
c
w
o
c
l
w
t
b
(
B
w
c
phowing hydropic degeneration and pyknosis of the nuclei (arrow) and of F1 fema
roup  3 of dam treated with high dose of BPA (E) showing increase in vacuolation of 
arrows), coagulative necrosis, sinusoidal dilatation, pyknosis and proliferation of k
o reconcile with the actions as estrogen agonists. Our study was
upported by the results of the hormonal levels which showed a
igniﬁcant increase in serum level of estrongen hormone accom-
anied with a signiﬁcant decrease of FSH level of both examined
oncentrations of BPA treated dam and F1 female groups which
ere more signiﬁcantly altered in F1 female groups. Additionally,
ur data recorded signiﬁcant increase in the level of lipid proﬁle;
holesterol, triglycerides, LDL with a signiﬁcant decrease of the
evel of HDL (Table 2).
Our results coincide with those reported by Grasselli et al. [18]
ho found that PBA treatment altered steroid hormone produc-
ion in rat ovary. The precise mechanism remains unclear [10]
ut they speculated that steroidogenic acute regulatory protein
StAR) and aromatase cytochrome P450 appeared to be targeted by
PA. Moreover, Peretz et al. [39] concluded that BPA may  interfere
ith the steroidogenesis by inhibiting cholesterol uptake, which
onsistent with our study concerning the results of lipid proﬁle
icture. Also, our data of lipid proﬁle came in harmony with thoseup 5) (D) showing sever hydropic degeneration and coagulative necrosis (arrow).
ic cells (arrows) and of F1 female (group 6) (F) showing sever hydropic degeneration
 cells (arrowheads) HE x 400.
recorded by Jiang et al. [25] who  found that Wister rats treated
with BPA up–regulated hepatic lipid metabolism and up-regulated
genes involved in lipogenesis pathway.
Concerning the histopathological ﬁndings of the examined
organs of our study which showed various lesions including degen-
eration in the epithelial lining of ovarian follicles, cystic dilatation of
endometrial gland, submucosal leukocytic inﬁltration and increase
in vaculation of hepatic cells with proliferation of kupffer cells,
which were more sever in groups 3& 6 of both dam and their F1
female (Figs. 5–7) that could be explained by the results of DNA
fragmentation previously mentioned. Sakuma et al. [46] supported
our attribution where they mentioned that oxidative DNA damage
has been implicated in a wide variety of pathological conditions.
Additionally, our ﬁndings regarding the effect on the expression
of ER,  could attribute our histopathological lesions. In the same
context Popa et al. [41] recorded that histopathologicial changes
can be explained by estrogen activity of BPA. In this respect, our
histopathologicial ﬁndings are in agreement with those ﬁndings
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etected by Newbold et al. [38] who mentioned that BPA has been
eported to cause signiﬁcant histological changes in the reproduc-
ive tract.
The histopathological perturbations in the hepatic tissues which
nvestigated in the present study could be reﬂect the functional
mpairment of the liver which may  be attribute the alteration in
he serum levels of GGT, ALP, total protein and glucose of the
reated rats of both dam and their F1 females. Previous studies of
arantino et al. [54] mentioned that BPA increased insulin resis-
ance and Makaji et al. [34] who found that BPA disturb glucose
omeostasis in animals. Similarly, Yildiz and Barlas [62] recorded
hat BPA treated rats revealed alteration in total protein, glucose
nd alkaline phosphatase. Also, Melzer et al. [36] mentioned that
PA signiﬁcantly correlated with elevations in the liver enzymes.
To sum up, our ﬁndings contribute to show that long- term
xposure to BPA at 50 and 200 mg/kg.b.wt. reﬂected total genomic
amage of DNA, signiﬁcant alterations in liver enzymes, lipid
roﬁle, antioxidant enzymes and reproductive hormones with up-
egulation in the expression of ER which were more signiﬁcantly
erturbed in group 3 and group 6 of both dam and F1 female rats.
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